ArticleArchives of gynecology and obstetrics2026
A nomogram integrating a novel uterine isthmus ratio (APTUIR), sonographic signs and clinical symptoms for predicting posterior deep endometriosis.
Article in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to propose a novel, reproducible transvaginal ultrasound (TVUS) measurement-anterior-posterior wall thickness of the uterine isthmus ratio (APTUIR)-and to construct a nomogram model integrating this parameter with other ultrasound assessments and clinical symptoms for predicting the risk of posterior pelvic deep endometriosis (DE).
methodsThis retrospective study included 362 patients with endometriosis (153 with posterior pelvic DE; 209 without) who underwent TVUS and surgery between 2021 and 2024. APTUIR, uterine white sliding lines (WSL), and clinical symptoms were assessed. LASSO regression was used to identify independent predictors and construct a nomogram. Model performance was evaluated by area under the curve (AUC), calibration curves and decision curve analysis (DCA) with internal validation (500 bootstrap samples).
resultsResults showed statistically significant differences between groups in dyspareunia, menstrual defecation abnormalities, CA125, uterine anteroposterior diameter, concomitant endometrial polyps (EPs), uterine posterior isthmus echo, uterine anterior WSL, uterine posterior WSL, ovarian kiss sign and APTUIR (p < 0.05). Four key predictors were identified: APTUIR, posterior uterine wall WSL, EPs, and menstrual bowel dysfunction. The nomogram demonstrated excellent predictive performance: AUC 0.933 (95% CI: 0.901-0.957), sensitivity of 85.0%, specificity of 88.0% and accuracy of 86.7%. The calibration curve of the nomogram demonstrated good consistency, whilst the decision curve indicated favourable clinical utility.
conclusionThe APTUIR-based nomogram provides a non-invasive, highly accurate tool for identifying high-risk posterior pelvic DE. It facilitates objective risk stratification and timely specialist referral, particularly in non-specialised settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.